IMU Biosciences is a pioneering biotech company coupling deep, population-level immune profiling with a proprietary ML & AI platform to build an immune atlas spanning the breadth of human health and disease. Its discovery platform is fuelling a new understanding of the immune system to power the future of translational research and clinical practice, from diagnostics to drug development and treatment response.